Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 52
- Markets & Stocks
US Election Results See Cannabis Stocks Plummet, DanCann Initiates Capital Reduction, & More from Stenocare
Cannabis stocks plunge on election results As the outcome of the US presidential election and numerous state-specific cannabis ballots dripped through yesterday, the markets reacted in tandem.
- Adult-Use
Florida & North Dakota Vote Against Cannabis Legalization, But Nebraska Approves Medical Cannabis Bills
Beyond the presidential result, yesterday key cannabis reform votes took place across numerous states, poised to have a significant impact the US cannabis industry.
- Uncategorized
What Does Trump’s America Mean for Cannabis?
As the most consequential US election in recent history comes to close after a long and turbulent campaign, the dust is beginning to settle on the prospective outlook for cannabis under the new administration.
- Opinion
Incumbent UK Providers Are the ‘Root Cause of the Sector’s Stagnation Since the Legalisation of Medical Cannabis in 2018′
Since the UK legalisation of CBPMs in 2018, the sector has faced slow adoption due to ineffective patient outreach, inconsistent supply chains and variable quality control from other providers.
- Adult-Use
Ohio’s Adult-Use Cannabis Market Hits $143m in Sales Since Launch
Ohio’s adult-use cannabis sales have now topped $140m since the retail market launched in earnest in August, according to the latest figures from Ohio Department of Commerce’s Division of Cannabis Control.
- Adult-Use
Germany Announces 2 Further Planned Adult-Use Cannabis Trials, but Legislation Not Yet in Place to Launch Them
Last week, Hanover and Frankfurt published ‘letters of intent’ to launch controlled cannabis sales to thousands of participants through new model projects, designed to gather data and inform future drug policy in Germany.
- Uncategorized
Deutschland kündigt 2 weitere geplante Cannabis-Studien für Erwachsene an, aber es gibt noch keine Gesetzgebung, um sie zu starten
Letzte Woche haben Hannover und Frankfurt Absichtserklärungen veröffentlicht, um den kontrollierten Verkauf von Cannabis an Tausende von Teilnehmern im Rahmen neuer Modellprojekte zu starten, die dazu dienen sollen, Daten zu sammeln und die zukünftige Drogenpolitik in Deutschland zu informieren.
- Press releases
OCT Announces Exclusive Joint Development Agreement With Ex-Google AI Experts, Hypatia AI to Develop an AI-Enabled Asset to Scale Its Drug Discovery Pipeline
Oxford Cannabinoid Technologies (“OCT” or “the Company”) is pleased to announce the successful completion of ‘proof of concept’ of its AI-enabled drug discovery asset, which it is developing in collaboration with New York-based tech consultancy, Hypatia AI (“Hypatia”).
- Uncategorized
New York’s Cannabis Market Could Top Sales of $3.3bn by 2027
New York’s legal cannabis market could see annual sales top $6bn within two years, according to new analysis from Whitney Economics.
- Uncategorized
Prohibition Partners und Mary Jane Berlin verkünden den Start des International Cannabis Business Day
Prohibition Partners und Mary Jane Berlin sind stolz, eine strategische Partnerschaft bekannt zu geben, um den International Cannabis Business Day im Rahmen des Mary Jane Berlin Festivals am 19. Juni 2025 zu veranstalten.
- Events
Prohibition Partners and Mary Jane Berlin Announce Launch of International Cannabis Business Day
Prohibition Partners and Mary Jane Berlin are proud to announce a strategic partnership to host the International Cannabis Business Day as part of the Mary Jane Berlin festival on June 19, 2025.
- Uncategorized
Cannabis Rescheduling Hearing Delayed Until Next Year
Just days after announcing the first tranche of witnesses for the critical upcoming public hearing on cannabis rescheduling, the Drug Enforcement Administration (DEA) has postponed it until early 2025.










